AG0037OT

3069-67-8 | 5-Methyl-1,3,4-oxadiazol-2(3H)-one

Chemical structure of 5-Methyl-1,3,4-oxadiazol-2(3H)-one, CAS 3069-67-8
AG0037OT
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 3069-67-8
Catalog Number AG0037OT(AGN-PC-0LQ166)
Chemical Name 5-Methyl-1,3,4-oxadiazol-2(3H)-one
IUPAC Name 5-methyl-3H-1,3,4-oxadiazol-2-one
InChI InChI=1S/C3H4N2O2/c1-2-4-5-3(6)7-2/h1H3,(H,5,6)
InChI Key NNXROHRFMWHXNH-UHFFFAOYSA-N
MDL Number MFCD07779431
Molecular Formula C3H4N2O2
Molecular Weight 100.0761
SMILES CC1=NNC(O1)=O
Synonyms
3069-67-8, 5-Methyl-1,3,4-oxadiazol-2(3H)-one, 5-methyl-1,3,4-oxadiazol-2-ol, 5-methyl-3H-1,3,4-oxadiazol-2-one, 5-methyl-1,3,4-oxadiazol-2(3H)one, 5-Methyl-3H-[1,3,4]oxadiazol-2-one, 5-methyl-2,3-dihydro-1,3,4-oxadiazol-2-one, 5-Methyl-1,3,4-oxadiazol-2[3H]one, 1,3,4-Oxadiazol-2(3H)-one, 5-methyl-, AC1NT4HC, SCHEMBL508673, CHEMBL504001, Jsp005787, CTK4G5725, DTXSID60415853, NNXROHRFMWHXNH-UHFFFAOYSA-N, ALBB-013469, ZX-AN012244, ZX-CM009239, 5-Methyl-[1,3,4]oxadiazol-2-ol, ANW-50087, MFCD15143213, ODC100480, ZINC22112808, 2-Methyl-1,3,4-oxadiazolin-5-one, 1,3,4-oxadiazol-2-ol, 5-methyl-, AKOS005174226, AKOS013464203, MCULE-8136744513, QC-4983, 5-methyl-3H-[1.3.4]oxadiazol-2-one, AJ-80969, AK-51334, BR-51334, CJ-17317, DS-15818, SC-84443, 1,3,4-Oxadiazol-2(3H)-one,5-methyl-, 5-methyl-1,3,4-oxadiazol-2-(3H)-one, TX-010602, 4CH-006660, FT-0658864, ST24033040, 5-Methyl-1,3,4-oxadiazol-2-ol, AldrichCPR, S-3865, 2-Methyl-5-oxo-4,5-dihydro-1,3,4-oxadiazole, 069M678, A820571, I14-6147, Z1741976939, InChI=1/C3H4N2O2/c1-2-4-5-3(6)7-2/h1H3,(H,5,6, ACN-S002070, 5-Methyl-1,3,4-oxadiazol-2 -one, CID5323974, 2-Chloro-N-(4-ethylcyclohexyl)acetamide, T3682, N/A,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited